October 14, 2024

Langeais, FR – Sylvan, a leading manufacturer of fungal biotechnology solutions, today announces the acquisition of French agaricus mushroom spawn producer EuroMycel from Bonduelle (BON.PA). The acquisition strengthens Sylvan’s position in the edible fungi market, expanding its capacity and capabilities in spawn production in Europe. Pending final legal approvals, the transaction is expected to close by the end of 2024.

Enhancing capabilities and expanding capacity

The acquisition of EuroMycel allows Sylvan to tap into additional production capacity which it requires as part of the rollout of their Strategy 2028, which will see an increased focus on the commercialisation of patented new strains and fungal solutions. EuroMycel, known for its high quality agaricus strains and expertise in grain-based spawn production, will enhance Sylvan’s ability to serve the rapidly growing demand for its products in the European market and beyond.

“We are excited to welcome Frédéric and the EuroMycel team to the Sylvan organisation. The company has built an excellent reputation as a supplier of reliable high-performance spawn, and they will continue to operate independently under the existing leadership team. We cannot wait to start the process of sharing scientific knowledge and expertise across the businesses.” said Iwan Brandsma, Sylvan Europe CEO and Group Chief Growth Officer. “This acquisition is a significant step forward in the delivery of our Strategy 2028 ambitions.”

Read the full press release here.